These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35963759)

  • 1. Chlamydia Trachomatis/Neisseria Gonorrhea Retesting Among Adolescents and Young Adults in a Primary Care Network.
    Teixeira da Silva D; Petsis D; Santos T; Mahajan A; Bonett S; Wood S
    J Adolesc Health; 2022 Nov; 71(5):545-551. PubMed ID: 35963759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retesting and repeat positivity following diagnosis of Chlamydia trachomatis and Neisseria gonorrhoea in New Zealand: a retrospective cohort study.
    Rose SB; Garrett SM; Stanley J; Pullon SRH
    BMC Infect Dis; 2017 Jul; 17(1):526. PubMed ID: 28754106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test of cure, retesting and extragenital testing practices for Chlamydia trachomatis and Neisseria gonorrhoeae among general practitioners in different socioeconomic status areas: A retrospective cohort study, 2011-2016.
    Wijers JNAP; van Liere GAFS; Hoebe CJPA; Cals JWL; Wolffs PFG; Dukers-Muijrers NHTM
    PLoS One; 2018; 13(3):e0194351. PubMed ID: 29538469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
    Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
    Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia trachomatis and Neisseria gonorrhoeae Retesting and Reinfection Rates in New Zealand Health Care Settings: Implications for Sexually Transmitted Infection Control.
    Rose SB; Garrett SM; Stanley J; Pullon SRH
    Sex Transm Dis; 2020 Mar; 47(3):151-157. PubMed ID: 31880741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the Gaps in Retesting for Chlamydia and Gonorrhea: Differences Across High-Volume Testing Departments in an Urban Health Care Setting.
    McCool-Myers M; Turner D; Henn MC; Sheth AN; Karlow SL; Kottke MJ
    Sex Transm Dis; 2021 Nov; 48(11):819-822. PubMed ID: 33859144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective screening for sexually transmitted infections among US service members with Chlamydia trachomatis or Neisseria gonorrhoeae infection.
    Bedno S; Hakre S; Clark S; Dear N; Milazzo M; McCoart A; Hassen Z; Liu H; Bianchi EJ; Darden JM; Paudel M; Malia JA; Peel SA; Scott PT; Petruccelli B
    PLoS One; 2023; 18(1):e0280783. PubMed ID: 36662886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partner notification and retesting for Chlamydia trachomatis and Neisseria gonorrhoeae: a case-note review in New Zealand primary care.
    Rose SB; Garrett SM; Kennedy J; Lund K; Hutchings D; Boyle C; Pullon SRH
    J Prim Health Care; 2018 Jun; 10(2):132-139. PubMed ID: 30068468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis.
    Fortenberry JD; Brizendine EJ; Katz BP; Wools KK; Blythe MJ; Orr DP
    Sex Transm Dis; 1999 Jan; 26(1):26-32. PubMed ID: 9918320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.
    Boiko I; Golparian D; Krynytska I; Unemo M
    APMIS; 2019 Sep; 127(9):627-634. PubMed ID: 31225920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of patients frequently tested and repeatedly infected with Chlamydia trachomatis in Southwest Limburg, the Netherlands.
    Wijers JNAP; Dukers-Muijrers NHTM; Hoebe CJPA; Wolffs PFG; van Liere GAFS
    BMC Public Health; 2020 Aug; 20(1):1239. PubMed ID: 32795362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing and validating a risk algorithm to diagnose Neisseria gonorrhoeae and Chlamydia trachomatis in symptomatic Rwandan women.
    Wall KM; Nyombayire J; Parker R; Ingabire R; Bizimana J; Mukamuyango J; Mazzei A; Price MA; Unyuzimana MA; Tichacek A; Allen S; Karita E
    BMC Infect Dis; 2021 Apr; 21(1):392. PubMed ID: 33910514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over-screening for chlamydia and gonorrhea among urban women age ≥25 years.
    Jackson JA; McNair TS; Coleman JS
    Am J Obstet Gynecol; 2015 Jan; 212(1):40.e1-6. PubMed ID: 24983680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antimicrobial resistance profiles of Neisseria gonorrhea and Chlamydia trachomatis isolated from individuals attending STD clinics in Kampala, Uganda.
    Nakku-Joloba E; Mboowa G; Ssengooba W; Kiyimba A; Kigozi E; Baluku H; Alinaitwe L; Nyote R; Kabahita JM; Mutumba P; Katabazi FA; Kiwanuka N; Sewankambo N; Kateete DP
    Afr Health Sci; 2022 Sep; 22(3):62-71. PubMed ID: 36910377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring quality STI care among adolescent female primary care patients in Philadelphia.
    Teixeira da Silva D; Makeneni S; Wall H; Bauermeister JA; Wood S
    Sex Transm Infect; 2023 Jun; 99(4):272-275. PubMed ID: 36868813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Get Yourself Tested 2011-2012: findings and prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae at an urban public health system.
    Roston A; Suleta K; Stempinski K; Keith L; Patel A
    Int J STD AIDS; 2015 Apr; 26(5):322-8. PubMed ID: 24867819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of physical restriction measures imposed during the two waves of COVID-19 on chlamydia and gonorrhea diagnoses in Belgium. Results of an sexually transmitted infection clinic.
    De Baetselier I; Apers L; Platteau T; Buyze J; Florence E; Kenyon C; Van den Bossche D;
    Int J STD AIDS; 2021 Oct; 32(11):998-1003. PubMed ID: 34096386
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study.
    Wynn A; Mussa A; Ryan R; Hansman E; Simon S; Bame B; Moreri-Ntshabele B; Ramogola-Masire D; Klausner JD; Morroni C
    BMC Infect Dis; 2022 Mar; 22(1):229. PubMed ID: 35255814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.
    Fajardo-Bernal L; Aponte-Gonzalez J; Vigil P; Angel-Müller E; Rincon C; Gaitán HG; Low N
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011317. PubMed ID: 26418128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.
    Guy RJ; Ward J; Causer LM; Natoli L; Badman SG; Tangey A; Hengel B; Wand H; Whiley D; Tabrizi SN; Shephard M; Fairley CK; Donovan B; Anderson DA; Regan DG; Maher L; Kaldor JM
    Lancet Infect Dis; 2018 Oct; 18(10):1117-1126. PubMed ID: 30303108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.